FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称GANDOTINIB
异名/同义词3-((4-CHLORO-2-FLUOROPHENYL)METHYL)-2-METHYL-N-(5-METHYL-1H-PYRAZOL-3-YL)-8- (MORPHOLIN-4-YLMETHYL)IMIDAZO(1,2-B)PYRIDAZIN-6-AMINE
3-(4-CHLORO-2-FLUOROBENZYL)-2-METHYL-N-(5-METHYL-1H-PYRAZOL-3-YL)-8- (MORPHOLINOMETHYL)IMIDAZO(1,2-B)PYRIDAZIN-6-AMINE
GANDOTINIB
GANDOTINIB [INN]
GANDOTINIB [USAN]
GANDOTINIB [WHO-DD]
IMIDAZO(1,2-B)PYRIDAZIN-6-AMINE, 3-((4-CHLORO-2-FLUOROPHENYL)METHYL)-2-METHYL-N-(5- METHYL-1H-PYRAZOL-3-YL)-8-(4-MORPHOLINYLMETHYL)-
LY2784544
LY-2784544
CAS登记号1229236-86-5
物质唯一标识(Unique Ingredient Identifier)ANC71R916O
分子式C23H25ClFN7O
国际化合物标识(International Chemical Identifier,InChI)SQSZANZGUXWJEA-UHFFFAOYSA-N
SMILESC(c1c2n(c(c(n2)C)Cc3c(F)cc(cc3)Cl)nc(c1)Nc4cc([nH]n4)C)N5CCOCC5
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System